ArticleFrontiers in oncology2015

Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth.

Melanie Sweetlove et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.